What is the annual revenue of BOL Pharma?
BOL Pharma annual revenue was $3.52 m in FY 2018 BOL Pharma revenue was $3.52 m in FY, 2018 which is a 16.8% year over year increase from the previous period. BOL Pharma's latest funding round in December 2018 was reported to be $199.9 k.
What are the target prices for bolt Biotherapeutics'stock?
5 brokerages have issued 1 year target prices for Bolt Biotherapeutics' stock. Their forecasts range from $33.00 to $45.00. On average, they expect Bolt Biotherapeutics' stock price to reach $39.80 in the next twelve months. This suggests a possible upside of 1,222.3% from the stock's current price.
What is the dividend yield of Bal pharma stock?
For the year ending March 2019 Bal Pharma has declared an equity dividend of 10.00% amounting to Rs 1 per share. At the current share price of Rs 40.30 this results in a dividend yield of 2.48%. The company has a good dividend track report and has consistently declared dividends for the last 5 years.
What is the upside for bolt Biotherapeutics'stock?
Their forecasts range from $33.00 to $45.00. On average, they expect Bolt Biotherapeutics' stock price to reach $39.80 in the next twelve months. This suggests a possible upside of 1,222.3% from the stock's current price. View analysts' price targets for Bolt Biotherapeutics or view top-rated stocks among Wall Street analysts.
What's the Bal Pharma share price today?
Bal Pharma share price was Rs 96.40 as on 13 Jun, 2022, 10:56 AM IST. Bal Pharma share price was down by 1.98% based on previous share price of Rs....
What is 52 week high/low of Bal Pharma share price?
Bal Pharma share price saw a 52 week high of Rs 148.85 and 52 week low of Rs 87.65.
What is the market cap of Bal Pharma?
Market Capitalization of Bal Pharma stock is Rs 153.78 Cr.
What are the key metrics to analyse Bal Pharma Share Price?
Key Metrics for Bal Pharma are: PE Ratio of Bal Pharma is 25.76 Earning per share of Bal Pharma is 3.74 Price/Sales ratio of Bal Pharma is 0.57 Pri...
What are the revenue and earnings for Bal Pharma ?
On Consoldiated basis, Bal Pharma reported a total income andprofit of Rs 77.75 Cr and Rs 2.19 respectively for quarter ending 2022-03-31.Total Inc...
Who are the peers for Bal Pharma in Pharmaceuticals sector?
Top 10 Peers for Bal Pharma are Medico Remedies Ltd., Alpa Laboratories Ltd., Par Drugs & Chemicals Ltd., Vivimed Labs Ltd., SMS Lifesciences India...
Who are the key owners of Bal Pharma stock?
Promoter holding has gone up from 44.84 (30 Jun 2021) to 49.57 (31 Mar 2022) Other investor holding have gone down from 55.16 (30 Jun 2021) to 50.1...
When is Boom Logistics' next earnings date?
Boom Logistics is scheduled to release its next quarterly earnings announcement on Wednesday, August 24th 2022. View our earnings forecast for Boo...
How were Boom Logistics' earnings last quarter?
Boom Logistics Limited (ASX:BOL) announced its quarterly earnings data on Wednesday, August, 15th. The company reported $0.00 EPS for the quarter,...
How often does Boom Logistics pay dividends? What is the dividend yield for Boom Logistics?
Boom Logistics declared a Interim dividend on Wednesday, March 16th. Investors of record on Tuesday, April 5th will be paid a dividend of 0.005 per...
Is Boom Logistics a good dividend stock?
Boom Logistics(ASX:BOL) pays an annual dividend of A$0.01 per share and currently has a dividend yield of 9.09%. BOL has a dividend yield higher th...
Who are Boom Logistics' key executives?
Boom Logistics' management team includes the following people: Mr. Tony Theodore Spassopoulos M.B.A. , CEO, MD & Director (Age 57, Pay $620.42k)...
Who are some of Boom Logistics' key competitors?
Some companies that are related to Boom Logistics include Andritz (ADRZF) , Austin Engineering (ANG) , Cool Technologies (WARM) , Coventry Grou...
What other stocks do shareholders of Boom Logistics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Boom Logistics investors own include Alkane Resources (ALK...
What is Boom Logistics' stock symbol?
Boom Logistics trades on the ASX under the ticker symbol "BOL."
How much money does Boom Logistics make?
Boom Logistics (ASX:BOL) has a market capitalization of $0.00 and generates $212.52 million in revenue each year.
What is Bal Pharma?
What is face value of stock?
Bal Pharma Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 143.70 Crore) operating in Pharmaceuticals sector. Bal Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2020.
About Boom Logistics
Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value. (₹) 10.00.
Headlines
Boom Logistics Limited provides lifting solutions and specialized labor services to mining and resources, wind, energy and utilities, infrastructure and construction, industrial maintenance, and telecommunication sectors in Australia. The company operates in two segments, Lifting Solutions and Labour Hire.
Boom Logistics (ASX:BOL) Frequently Asked Questions
Can You Imagine How Jubilant Boom Logistics' (ASX:BOL) Shareholders Feel About Its 113% Share Price Gain?
When will Bolt Biotherapeutics release its earnings?
Boom Logistics is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022. View our earnings forecast for Boom Logistics.
How much does Bolt Biotherapeutics make?
Bolt Biotherapeutics is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021. View our earnings forecast for Bolt Biotherapeutics.
When does Bolt Biotherapeutics' lock up period expire?
How much money does Bolt Biotherapeutics make? Bolt Biotherapeutics has a market capitalization of $448.80 million and generates $230,000.00 in revenue each year. The company earns $-60,730,000.00 in net income (profit) each year or ($22.26) on an earnings per share basis.
News
Bolt Biotherapeutics' lock-up period expires on Wednesday, August 4th. Bolt Biotherapeutics had issued 11,500,000 shares in its IPO on February 5th. The total size of the offering was $230,000,000 based on an initial share price of $20.00.
Corporate Action
Trade Spotlight | What should you do with eClerx Services, Balaji Amines, Coal India, Bal Pharma and Birlasoft? Jan 04 2022 07:01 AM
About the Company
ACUITE has upgraded the credit ratings of the Company, as follows. 01. Long Term Fund based facilities Upgraded to ACUITE BBB- stable from (....
Where is Bol Pharma?
Bal Pharma Ltd is engaged in the manufacturing of API, finished formulations, ayurvedic and research and development. They are one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.
Is hemp a TSE?
The company, which is commonly known as BOL Pharma, grows medical cannabis and produces cannabinoid products that are supplied to patients and pharmacies in Israel. It is aiming to produce for export markets in Europe, Canada and Australia. It is focused on becoming a global leader in pharmaceutical drugs intended to address “unmet medical needs ...
